Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Health status of ayahuasca users.

Barbosa PC, Mizumoto S, Bogenschutz MP, Strassman RJ.

Drug Test Anal. 2012 Jul-Aug;4(7-8):601-9. doi: 10.1002/dta.1383. Epub 2012 Jul 4. Review.

PMID:
22761152
[PubMed - indexed for MEDLINE]
2.

Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.

Dos Santos RG, Valle M, Bouso JC, Nomdedéu JF, Rodríguez-Espinosa J, McIlhenny EH, Barker SA, Barbanoj MJ, Riba J.

J Clin Psychopharmacol. 2011 Dec;31(6):717-26. doi: 10.1097/JCP.0b013e31823607f6.

PMID:
22005052
[PubMed - indexed for MEDLINE]
3.

Pharmacology of ayahuasca administered in two repeated doses.

Dos Santos RG, Grasa E, Valle M, Ballester MR, Bouso JC, Nomdedéu JF, Homs R, Barbanoj MJ, Riba J.

Psychopharmacology (Berl). 2012 Feb;219(4):1039-53. doi: 10.1007/s00213-011-2434-x. Epub 2011 Aug 13.

PMID:
21842159
[PubMed - indexed for MEDLINE]
4.

Assessment of addiction severity among ritual users of ayahuasca.

Fábregas JM, González D, Fondevila S, Cutchet M, Fernández X, Barbosa PC, Alcázar-Córcoles MÁ, Barbanoj MJ, Riba J, Bouso JC.

Drug Alcohol Depend. 2010 Oct 1;111(3):257-61. doi: 10.1016/j.drugalcdep.2010.03.024. Epub 2010 Jun 15.

PMID:
20554400
[PubMed - indexed for MEDLINE]
5.

Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.

Santos RG, Landeira-Fernandez J, Strassman RJ, Motta V, Cruz AP.

J Ethnopharmacol. 2007 Jul 25;112(3):507-13. Epub 2007 Apr 25.

PMID:
17532158
[PubMed - indexed for MEDLINE]
6.

Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users.

Bouso JC, Fábregas JM, Antonijoan RM, Rodríguez-Fornells A, Riba J.

Psychopharmacology (Berl). 2013 Dec;230(3):415-24. doi: 10.1007/s00213-013-3167-9. Epub 2013 Jun 21.

PMID:
23793226
[PubMed - indexed for MEDLINE]
7.

The globalization of ayahuasca: harm reduction or benefit maximization?

Tupper KW.

Int J Drug Policy. 2008 Aug;19(4):297-303. doi: 10.1016/j.drugpo.2006.11.001. Epub 2006 Dec 4.

PMID:
18638702
[PubMed - indexed for MEDLINE]
8.

Hypotheses regarding the mechanisms of ayahuasca in the treatment of addictions.

Liester MB, Prickett JI.

J Psychoactive Drugs. 2012 Jul-Aug;44(3):200-8.

PMID:
23061319
[PubMed - indexed for MEDLINE]
9.

Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.

McKenna DJ.

Pharmacol Ther. 2004 May;102(2):111-29. Review.

PMID:
15163593
[PubMed - indexed for MEDLINE]
10.

Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers.

Barbanoj MJ, Riba J, Clos S, Giménez S, Grasa E, Romero S.

Psychopharmacology (Berl). 2008 Feb;196(2):315-26. Epub 2007 Nov 21.

PMID:
18030450
[PubMed - indexed for MEDLINE]
11.

Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study.

Bouso JC, González D, Fondevila S, Cutchet M, Fernández X, Ribeiro Barbosa PC, Alcázar-Córcoles MÁ, Araújo WS, Barbanoj MJ, Fábregas JM, Riba J.

PLoS One. 2012;7(8):e42421. doi: 10.1371/journal.pone.0042421. Epub 2012 Aug 8.

PMID:
22905130
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.

McIlhenny EH, Riba J, Barbanoj MJ, Strassman R, Barker SA.

Biomed Chromatogr. 2011 Sep;25(9):970-84. doi: 10.1002/bmc.1551. Epub 2010 Nov 5.

PMID:
21058415
[PubMed - indexed for MEDLINE]
13.

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers.

Riba J, Rodríguez-Fornells A, Urbano G, Morte A, Antonijoan R, Montero M, Callaway JC, Barbanoj MJ.

Psychopharmacology (Berl). 2001 Feb;154(1):85-95.

PMID:
11292011
[PubMed - indexed for MEDLINE]
14.

Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.

Riba J, McIlhenny EH, Valle M, Bouso JC, Barker SA.

Drug Test Anal. 2012 Jul-Aug;4(7-8):610-6. doi: 10.1002/dta.1344. Epub 2012 Apr 19.

PMID:
22514127
[PubMed - indexed for MEDLINE]
15.

Ayahuasca and the process of regulation in Brazil and internationally: implications and challenges.

Labate BC, Feeney K.

Int J Drug Policy. 2012 Mar;23(2):154-61. doi: 10.1016/j.drugpo.2011.06.006.

PMID:
21856141
[PubMed - indexed for MEDLINE]
16.

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.

Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ.

J Pharmacol Exp Ther. 2003 Jul;306(1):73-83. Epub 2003 Mar 26.

PMID:
12660312
[PubMed - indexed for MEDLINE]
Free Article
17.

Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture.

Freedland CS, Mansbach RS.

Drug Alcohol Depend. 1999 May 3;54(3):183-94.

PMID:
10372792
[PubMed - indexed for MEDLINE]
18.

Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.

Gable RS.

Addiction. 2007 Jan;102(1):24-34. Review.

PMID:
17207120
[PubMed - indexed for MEDLINE]
19.

Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.

dos Santos RG.

J Psychoactive Drugs. 2013 Jan-Mar;45(1):68-78. Review.

PMID:
23662333
[PubMed - indexed for MEDLINE]
20.

Consumption of ayahuasca by children and pregnant women: medical controversies and religious perspectives.

Labate BC.

J Psychoactive Drugs. 2011 Jan-Mar;43(1):27-35. doi: 10.1080/02791072.2011.566498.

PMID:
21615005
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk